跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Pantazo - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Pantazo
Approved
STANDARD
Pantazo
Laboratoires Panpharma S.A.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
ef9c543c6f939cf9
Company
Laboratoires Panpharma S.A.
Type
Standard
Approval Details
Approval Id
ef9c543c6f939cf9
Drug Approval Philippines Name
Pantazo
Product Name
Pantazo
Registration Number
DR-XY39622
Brand Name
Pantazo
Generic Name
Piperacillin (as Sodium) + Tazobactam (as Sodium)
Dosage Form
Solution for Infusion (IV)
Dosage Strength
2g/ 250mg
Manufacturer
Laboratoires Panpharma S.A.
Importer
PANPHARMA MEINZ PHARMACEUTICAlS
Distributor
PANPHARMA MEINZ PHARMACEUTICAlS
Issuance Date
26 October 2021
Expiry Date
14 June 2026
Pharmacologic Category
Antibacterial
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
ef9c543c6f939cf9
Type
Standard
Back to Philippines FDA Approvals